The fact that chitinases are a factor in host antiparasite responses and in asthmatic TH2 inflammation led to the hypothesis that asthma may be a parasite-independent antiparasite response [10], which again suggests that inhibition of AMCase is a potential target for asthma therapy [9–12]. The gene discussed is CHIA; the disease is asthma.